Transforming Clinical Trials with Alexander Saint-Amand

Topics covered
Popular Clips
Questions from this episode
- Asked by 107 people
- Asked by 76 people
- Asked by 71 people
- Asked by 27 people
- Asked by 20 people
- Asked by 7 people
- Asked by 6 people
- Asked by 6 people
- Asked by 5 people
- Asked by 5 people
Episode Highlights
Hybrid Approach
Topography's hybrid approach to clinical trials combines technology and services to enhance efficiency and participation. emphasizes the importance of supporting physicians with both technological tools and hands-on assistance, as doctors often require guidance in patient recruitment and trial selection 1. This dual approach aims to make clinical trials more accessible and equitable, addressing systemic barriers that have long hindered progress. notes, "The pandemic laid out a roadmap for doing trials much more quickly in the community setting, reaching far more patients."
The pandemic laid out a roadmap for doing trials much more quickly in the community setting, reaching far more patients.
---
By leveraging these insights, Topography seeks to transform the clinical trial landscape, making advanced care more widely available 2.
  Â
Network Building
Building a robust network is crucial for Topography's success in clinical trials. discusses the challenges of establishing a critical mass of providers, patients, and pharma companies to create a viable platform 3. This network effect is essential for proving the platform's value and gaining trust from all parties involved. explains, "You have to kind of build a critical mass of technology which costs something and then you have to get a little bit of demand and then you have to get a little bit of supply and then you have to get a few patients."
You have to kind of build a critical mass of technology which costs something and then you have to get a little bit of demand and then you have to get a little bit of supply and then you have to get a few patients.
---
Additionally, Topography aims to empower physicians by giving them a stake in the research process, fostering a sense of ownership and collaboration 4.
Related Episodes


Scaling Medicaid Innovation with Afia Asamoah, Rajaie Batniji, and Sanjay Basu
Answers 383 questions

Reengineering Healthcare and Medicine with Technology with Vineeta Agarwala
Answers 383 questions

Adapting Biopharma to AI with Greg Meyers
Answers 383 questions

Network Medicine with Jonathan Swerdlin and Mark Hyman
Answers 383 questions

AI + a16z with Vijay Pande
Answers 383 questions

AI is Here. Now What?
Answers 383 questions

Clinical Copilots: Augmenting Human Care with Suchi Saria
Answers 383 questions

Biotech Revolution with Software Engineering Daily
Answers 383 questions

AI in Pharmaceutical R&D with Kim Branson
Answers 383 questions

Adapting Biopharma to AI with Greg Meyers
Answers 383 questions

The Transformative Power of AI in Science with Pushmeet Kohli
Answers 383 questions

Expert AI as a Healthcare Superpower
Answers 383 questions

Adapting Biopharma to AI: A 2024 Update with Greg Meyers
Answers 383 questions

AI-Enabled Continuity of Care with Ed and Todd Park
Answers 383 questions

Grand Challenges in Healthcare AI with Vijay Pande and Julie Yoo
Answers 383 questions
